Denmark's Ascendis Pharma is planning to launch its once-weekly therapy for a form of dwarfism in the US in the second quarter, after securing FDA approval for the drug. Created using Ascendis' drug ...

Achondroplasia is a genetic bone growth disorder that causes disproportionate dwarfism, where individuals develop short limbs and a torso of typical size. It occurs in roughly 1 in 20,000 to 30,000 ...

The major stock indexes are now trading higher after significant losses earlier in the day. The S&P 500 is up 0.1% after falling 1.2% during intraday trading. If it closes higher today, it would be ...

Baron Franz Nopcsa was a self-taught palaeontologist who spent his life pushing the boundaries of scientific understanding. He is credited with founding the field of palaeobiology and was the first to ...